BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 17873771)

  • 1. The glare hypothesis of macular pigment function.
    Stringham JM; Hammond BR
    Optom Vis Sci; 2007 Sep; 84(9):859-64. PubMed ID: 17873771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular pigment and visual performance under glare conditions.
    Stringham JM; Hammond BR
    Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort.
    Stringham JM; Garcia PV; Smith PA; McLin LN; Foutch BK
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7406-15. PubMed ID: 21296819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of the AcrySof natural lens on glare disability and photostress.
    Hammond BR; Bernstein B; Dong J
    Am J Ophthalmol; 2009 Aug; 148(2):272-276.e2. PubMed ID: 19426959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
    Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glare disability, photostress recovery, and chromatic contrast: relation to macular pigment and serum lutein and zeaxanthin.
    Hammond BR; Fletcher LM; Elliott JG
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):476-81. PubMed ID: 23211814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of visual sensitivity of older subjects: association with macular pigment density.
    Hammond BR; Wooten BR; Snodderly DM
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):397-406. PubMed ID: 9478000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensation for light loss due to filtering by macular pigment: relation to hue cancellation.
    Stringham JM; Hammond BR
    Ophthalmic Physiol Opt; 2007 May; 27(3):232-7. PubMed ID: 17470235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS.
    Nolan JM; Loughman J; Akkali MC; Stack J; Scanlon G; Davison P; Beatty S
    Vision Res; 2011 Mar; 51(5):459-69. PubMed ID: 21237188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing performance while avoiding damage: a contribution of macular pigment.
    Stringham JM; Snodderly DM
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6298-306. PubMed ID: 23982840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between macular pigment and visual performance.
    Loughman J; Akkali MC; Beatty S; Scanlon G; Davison PA; O'Dwyer V; Cantwell T; Major P; Stack J; Nolan JM
    Vision Res; 2010 Jun; 50(13):1249-56. PubMed ID: 20394766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of macular pigment on heterochromatic luminance contrast.
    Renzi LM; Hammond BR
    Exp Eye Res; 2010 Dec; 91(6):896-900. PubMed ID: 20883691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensation for light loss resulting from filtering by macular pigment: relation to the S-cone pathway.
    Stringham JM; Hammond BR; Wooten BR; Snodderly DM
    Optom Vis Sci; 2006 Dec; 83(12):887-94. PubMed ID: 17164681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of filtering by the macular carotenoids on contrast sensitivity measured under simulated blue haze conditions.
    Hammond BR; Wooten BR; Engles M; Wong JC
    Vision Res; 2012 Jun; 63():58-62. PubMed ID: 22588116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular pigment: a test of the acuity hypothesis.
    Engles M; Wooten B; Hammond B
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2922-31. PubMed ID: 17525229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between the macular carotenoids, lutein and zeaxanthin, and temporal vision.
    Renzi LM; Hammond BR
    Ophthalmic Physiol Opt; 2010 Jul; 30(4):351-7. PubMed ID: 20492542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular pigment assessment by motion photometry.
    Moreland JD
    Arch Biochem Biophys; 2004 Oct; 430(2):143-8. PubMed ID: 15369811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
    Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
    Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome.
    Aleman TS; Duncan JL; Bieber ML; de Castro E; Marks DA; Gardner LM; Steinberg JD; Cideciyan AV; Maguire MG; Jacobson SG
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1873-81. PubMed ID: 11431456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical method for measuring macular pigment optical density.
    Wooten BR; Hammond BR; Land RI; Snodderly DM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2481-9. PubMed ID: 10509640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.